GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » PB Ratio

Shanghai Universal Biotech Co (SZSE:301166) PB Ratio : 1.22 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Universal Biotech Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-26), Shanghai Universal Biotech Co's share price is ¥29.88. Shanghai Universal Biotech Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥24.48. Hence, Shanghai Universal Biotech Co's PB Ratio of today is 1.22.

The historical rank and industry rank for Shanghai Universal Biotech Co's PB Ratio or its related term are showing as below:

SZSE:301166' s PB Ratio Range Over the Past 10 Years
Min: 1.09   Med: 1.94   Max: 4.27
Current: 1.22

During the past 7 years, Shanghai Universal Biotech Co's highest PB Ratio was 4.27. The lowest was 1.09. And the median was 1.94.

SZSE:301166's PB Ratio is ranked better than
76.83% of 1312 companies
in the Biotechnology industry
Industry Median: 2.5 vs SZSE:301166: 1.22

During the past 12 months, Shanghai Universal Biotech Co's average Book Value Per Share Growth Rate was -2.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 57.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 59.40% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Universal Biotech Co was 96.20% per year. The lowest was 35.20% per year. And the median was 63.85% per year.

Back to Basics: PB Ratio


Shanghai Universal Biotech Co PB Ratio Historical Data

The historical data trend for Shanghai Universal Biotech Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Universal Biotech Co PB Ratio Chart

Shanghai Universal Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - 4.27 1.84 1.57

Shanghai Universal Biotech Co Quarterly Data
Dec18 Mar19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 1.76 1.66 1.57 1.23

Competitive Comparison of Shanghai Universal Biotech Co's PB Ratio

For the Biotechnology subindustry, Shanghai Universal Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Universal Biotech Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Universal Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Universal Biotech Co's PB Ratio falls into.



Shanghai Universal Biotech Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shanghai Universal Biotech Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=29.88/24.478
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Shanghai Universal Biotech Co  (SZSE:301166) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Shanghai Universal Biotech Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Universal Biotech Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Universal Biotech Co (SZSE:301166) Business Description

Traded in Other Exchanges
N/A
Address
No. 1690 Kongjiang Road, Room 1505, Yangpu District, Shanghai, CHN, 200082
Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.

Shanghai Universal Biotech Co (SZSE:301166) Headlines

No Headlines